Rare lephants
Screener

Immunovant Inc.

IMVT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jan 17, 2025 FORM 4
4 Jan 15, 2025 FORM 4
SCHEDULE 13D/A Jan 15, 2025
8-K Jan 14, 2025 8-K
8-K Jan 13, 2025 8-K
4 Jan 10, 2025 FORM 4
4 Jan 10, 2025 FORM 4
4 Dec 18, 2024 FORM 4
3 Dec 18, 2024 FORM 3
4 Dec 4, 2024 FORM 4
4 Dec 4, 2024 FORM 4
144 Dec 2, 2024
144 Dec 2, 2024
4 Nov 22, 2024 FORM 4
4 Nov 22, 2024 FORM 4
4 Nov 22, 2024 FORM 4
4 Nov 22, 2024 FORM 4
4 Nov 20, 2024 FORM 4
3 Nov 20, 2024 FORM 3
SC 13G/A Nov 12, 2024
10-Q Nov 7, 2024 10-Q
8-K Nov 7, 2024 8-K
4 Oct 25, 2024 FORM 4
4 Oct 25, 2024 FORM 4
4 Oct 25, 2024 FORM 4
← Newer Page 7 of 26 · 641 filings Older →